ABBV P/E Ratio
Share price divided by earnings per share — what investors pay for each dollar of profit.
P/E Ratio
Latest: 71.1 (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | 14.9 |
| 2020Q4 | 30.6 |
| 2021Q1 | 31.6 |
| 2021Q2 | 25.4 |
| 2021Q3 | 21.7 |
| 2021Q4 | 18.0 |
| 2022Q1 | 20.1 |
| 2022Q2 | 18.9 |
| 2022Q3 | 15.8 |
| 2022Q4 | 21.7 |
| 2023Q1 | 33.8 |
| 2023Q2 | 25.1 |
| 2023Q3 | 37.4 |
| 2023Q4 | 52.5 |
| 2024Q1 | 50.4 |
| 2024Q2 | 53.9 |
| 2024Q3 | 65.2 |
| 2024Q4 | 71.0 |
| 2025Q1 | 86.3 |
| 2025Q2 | 86.3 |
| 2025Q3 | 172.8 |
| 2025Q4 | 96.8 |
| 2026Q1 | 107.1 |
| 2026Q2 | 71.1 |
Other ABBV Charts
More quarter-by-quarter fundamentals for AbbVie Inc.
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Latest P/E Ratio: 71.1 (2026Q2); -17.6% YoY; +17.0% CAGR since 2013Q3 (12.75y).
Across the 52 quarters from 2013Q3 to 2026Q2, P/E Ratio ranged from 9.6 in 2013Q3 to 172.8 in 2025Q3.
Chart and table show the latest 24 of 52 quarters.